You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API oxymetazoline hydrochloride ophthalmic

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing oxymetazoline hydrochloride ophthalmic

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
RVL Pharmaceuticals Inc	UPNEEQ	oxymetazoline hydrochloride ophthalmic	73687-062	CALCIUM CHLORIDE
RVL Pharmaceuticals Inc	UPNEEQ	oxymetazoline hydrochloride ophthalmic	73687-062	HYDROCHLORIC ACID
RVL Pharmaceuticals Inc	UPNEEQ	oxymetazoline hydrochloride ophthalmic	73687-062	HYPROMELLOSE
RVL Pharmaceuticals Inc	UPNEEQ	oxymetazoline hydrochloride ophthalmic	73687-062	MAGNESIUM CHLORIDE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for oxymetazoline hydrochloride ophthalmic

Excipient focus: CALCIUM CHLORIDE

oxymetazoline hydrochloride ophthalmic drug variants containing CALCIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing CALCIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

oxymetazoline hydrochloride ophthalmic drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

oxymetazoline hydrochloride ophthalmic drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM CHLORIDE

oxymetazoline hydrochloride ophthalmic drug variants containing MAGNESIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing MAGNESIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POTASSIUM CHLORIDE

oxymetazoline hydrochloride ophthalmic drug variants containing POTASSIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing POTASSIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM ACETATE

oxymetazoline hydrochloride ophthalmic drug variants containing SODIUM ACETATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing SODIUM ACETATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

oxymetazoline hydrochloride ophthalmic drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CITRATE

oxymetazoline hydrochloride ophthalmic drug variants containing SODIUM CITRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing SODIUM CITRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

oxymetazoline hydrochloride ophthalmic drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
RVL Pharmaceuticals Inc	oxymetazoline hydrochloride ophthalmic	73687-062
>Company	>Ingredient	>NDC

oxymetazoline hydrochloride ophthalmic drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.